Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab

NCT05319639 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

51

Enrollment

OTHER_GOV

Sponsor class

Conditions

Gastric Cancer Stage IV

Interventions

DRUG: Oxaliplatin
DRUG: Levo-Leucovorin
DRUG: 5-fluorouracil
DRUG: Paclitaxel
DRUG: Irinotecan
DRUG: Tislelizumab

Sponsor

Fujian Cancer Hospital